Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Drug News & Perspectives|December 24, 2004
Cytokines and IDDM: implications for etiology and therapyB Balasa, N Sarvetnick
Journal of Autoimmunity|April 1, 1996
The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetesB Balasa, N Sarvetnick
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouseW S Gallichan, B Balasa, J D Davies, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravisB Balasa, C Deng, J Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouseA La Cava, B Balasa, A Good, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytesB Balasa, J D Davies, J Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic miceB Balasa, T Krahl, G Patstone, et al.
Pageof 11